Episode 17: Amy Fenton Parker, President and CEO at Batten Disease Support and Research Organization (BDSRA)

Episode 17 January 12, 2022 00:39:58
Episode 17: Amy Fenton Parker, President and CEO at Batten Disease Support and Research Organization (BDSRA)
Few & Far Between: How Biotech Gets Built
Episode 17: Amy Fenton Parker, President and CEO at Batten Disease Support and Research Organization (BDSRA)

Jan 12 2022 | 00:39:58

/

Show Notes

Why are advocacy and accessibility so important to rare diseases such as Batten Disease? On this week’s Few & Far Between podcast episode, Biorasi’s Becky Knockemus talks with Amy Fenton Parker, President and CEO at Batten Disease Support and Research Organization (BDSRA).

Other Episodes

Episode 62

October 22, 2025 00:44:15
Episode Cover

Episode 62: Ken Suzuki, Chief Marketing Officer at Nautilus Biotechnology

When is the right time for a biotech to bring in a Chief Marketing Officer/CMO? Find out in our latest episode of the Biorasi...

Listen

Episode 60

September 17, 2025 00:42:11
Episode Cover

Episode 60: Part Two: Yochi Slonim, Co-Founder and CEO at Anima Biotech

Can AI see and talk to human cells? Find out in today's episode of the Biorasi Few & Far Between podcast. Host Chris O'Brien...

Listen

Episode 64

November 11, 2025 00:47:30
Episode Cover

Video Episode 64 - Professor Justin Stebbing

Will GLP-1's one day replace our morning coffee? Find out in a special video episode of the Few & Far Between podcast! Host Chris...

Listen